Marcela Guimarães , Daniela Luz , Elisabeth de Fátima Pires Augusto , Lucia Vieira , Maricilia Silva Costa , Roxane Maria Fontes Piazza , José Geraldo da Cruz Pradella
{"title":"“通过重组大肠杆菌生产抗志贺毒素2的单链病毒抗体片段的成本效益方法”的勘误[c]。参考文献。生物技术。10 (2025)100310 [j]","authors":"Marcela Guimarães , Daniela Luz , Elisabeth de Fátima Pires Augusto , Lucia Vieira , Maricilia Silva Costa , Roxane Maria Fontes Piazza , José Geraldo da Cruz Pradella","doi":"10.1016/j.crbiot.2025.100315","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":52676,"journal":{"name":"Current Research in Biotechnology","volume":"10 ","pages":"Article 100315"},"PeriodicalIF":4.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to “Cost-effective production process of scFv antibody fragments against Shiga toxin 2 via recombinant E. coli” [Curr. Res. Biotechnol. 10 (2025) 100310]\",\"authors\":\"Marcela Guimarães , Daniela Luz , Elisabeth de Fátima Pires Augusto , Lucia Vieira , Maricilia Silva Costa , Roxane Maria Fontes Piazza , José Geraldo da Cruz Pradella\",\"doi\":\"10.1016/j.crbiot.2025.100315\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":52676,\"journal\":{\"name\":\"Current Research in Biotechnology\",\"volume\":\"10 \",\"pages\":\"Article 100315\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Research in Biotechnology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590262825000462\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Research in Biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590262825000462","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Corrigendum to “Cost-effective production process of scFv antibody fragments against Shiga toxin 2 via recombinant E. coli” [Curr. Res. Biotechnol. 10 (2025) 100310]
期刊介绍:
Current Research in Biotechnology (CRBIOT) is a new primary research, gold open access journal from Elsevier. CRBIOT publishes original papers, reviews, and short communications (including viewpoints and perspectives) resulting from research in biotechnology and biotech-associated disciplines.
Current Research in Biotechnology is a peer-reviewed gold open access (OA) journal and upon acceptance all articles are permanently and freely available. It is a companion to the highly regarded review journal Current Opinion in Biotechnology (2018 CiteScore 8.450) and is part of the Current Opinion and Research (CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.